发明名称 Methods for Inhibiting the Development of Huntington's Disease
摘要 This invention relates to Huntington's disease and more specifically to methods for inhibiting the development of or treating Huntington's disease by administering estrogen, testosterone, precursors thereof or combinations thereof.
申请公布号 US2014329789(A1) 申请公布日期 2014.11.06
申请号 US201414334643 申请日期 2014.07.17
申请人 Carnazza James A. 发明人 Carnazza James A.
分类号 G01N33/74;A61K31/568;A61K31/565 主分类号 G01N33/74
代理机构 代理人
主权项 1. A method of determining if administration of 17β-estradiol or testosterone is needed in an individual having a Huntington's Disease (HD) gene with a number of CAG repeats between about 36 and about 120, the method comprising: a. assessing a level of 17β-estradiol, free testosterone, or total testosterone in the individual to determine if the level is below a normal level; and b. comparing the level to a normal level of about 100 pg/ml for 17β-estradiol, to a normal level of about 20 pg/ml for free testosterone, or to a normal level of about 300 ng/dL for total testosterone, thereby determining if the level is below a normal level; wherein a level below a normal level indicates a need to administer an amount of 17β-estradiol or an amount of testosterone, and a level at or above a normal level indicates a lack of a need to administer an amount of 17β-estradiol or an amount of testosterone; and wherein the assessing a level of 17β-estradiol and the need to administer an amount of 17β-estradiol are for a female individual, and wherein the assessing a level of free testosterone or total testosterone and the need to administer an amount of testosterone are for a male individual.
地址 Holden MA US